A new antibiotic, amicetin, isolated from Streptomyces vinaceusdrappus and known to contain a cytosine-paramino-benzoic acid and alpha-methyl-serine moiety has been shown to prolong survival time of mice with Line 82 leukemia. It has been without significant effect in 2 other strains of leukemia similarly studied.